HIKAL Financial Statement Analysis
|
||
|
The Revenues of HIKAL have decreased by -11.79% YoY .
The Earnings Per Share (EPS) of HIKAL has increased by 30.32 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
HIKAL Last 5 Annual Financial Results
[BOM: 524735|NSE : HIKAL]
| Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|---|
| Revenues | ₹1,785 Cr | ₹2,023 Cr | ₹1,943 Cr | ₹1,720 Cr | ₹1,507 Cr |
| Expenses | ₹1,518 Cr | ₹1,766 Cr | ₹1,602 Cr | ₹1,398 Cr | ₹1,234 Cr |
| Operating Profit (Excl OI) | ₹267 Cr | ₹257 Cr | ₹341 Cr | ₹323 Cr | ₹273 Cr |
| Other Income | ₹2.50 Cr | ₹5.41 Cr | ₹4.89 Cr | ₹4.98 Cr | ₹3.70 Cr |
| Interest | ₹56 Cr | ₹48 Cr | ₹31 Cr | ₹36 Cr | ₹52 Cr |
| Depreciation | ₹118 Cr | ₹109 Cr | ₹96 Cr | ₹85 Cr | ₹82 Cr |
| Profit Before Tax | ₹96 Cr | ₹105 Cr | ₹219 Cr | ₹206 Cr | ₹127 Cr |
| Profit After Tax | ₹70 Cr | ₹78 Cr | ₹160 Cr | ₹133 Cr | ₹84 Cr |
| Consolidated Net Profit | ₹70 Cr | ₹78 Cr | ₹160 Cr | ₹133 Cr | ₹84 Cr |
| Earnings Per Share (Rs) | ₹7.35 | ₹5.64 | ₹6.36 | ₹13.02 | ₹10.80 |
| PAT Margin (%) | 4.88 | 3.90 | 3.87 | 8.26 | 7.74 |
| ROE(%) | 7.41 | 6.00 | 7.12 | 16.04 | 15.22 |
| ROCE(%) | 9.88 | 7.82 | 8.47 | 15.21 | 16.15 |
| Total Debt/Equity(x) | 0.60 | 0.69 | 0.66 | 0.63 | 0.65 |
Key Financials |
||
| Market Cap | : | ₹ 2,868.6 Cr |
| Revenue (TTM) | : | ₹ 1,833.4 Cr |
| Net Profit(TTM) | : | ₹ 63.3 Cr |
| EPS (TTM) | : | ₹ 5.1 |
| P/E (TTM) | : | 45.3 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| HIKAL | -2.5% | -7.1% | -38.8% |
| SUN PHARMACEUTICAL INDUSTRIES | 0.2% | 2.3% | -9.3% |
| DIVIS LABORATORIES | -1.3% | 9.1% | 16.7% |
| CIPLA | 0.2% | -0.6% | -3.8% |
| TORRENT PHARMACEUTICALS | 0.6% | 1% | 10.8% |
| DR REDDYS LABORATORIES | 0.6% | -3.5% | -4.3% |
| MANKIND PHARMA | -5% | -8.8% | -14.2% |
| ZYDUS LIFESCIENCES | -3.2% | -4.5% | -6.8% |
| LUPIN | 0.4% | 2.4% | -11% |
HIKAL Revenues
[BOM: 524735|NSE : HIKAL]
| Y-o-Y | -11.79 % |
| 5 Yr CAGR | 4.31 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,785 Cr | -11.79 | |
| Mar2024 | ₹2,023 Cr | 4.13 | |
| Mar2023 | ₹1,943 Cr | 12.92 | |
| Mar2022 | ₹1,720 Cr | 14.14 | |
| Mar2021 | ₹1,507 Cr | - | |
HIKAL Operating Profit
[BOM: 524735|NSE : HIKAL]
| Y-o-Y | 3.86 % |
| 5 Yr CAGR | -0.57 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹267 Cr | 3.86 | |
| Mar2024 | ₹257 Cr | -24.51 | |
| Mar2023 | ₹341 Cr | 5.47 | |
| Mar2022 | ₹323 Cr | 18.20 | |
| Mar2021 | ₹273 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 17.70 % |
| 5 Yr CAGR | -4.68 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 14.96% | 17.70 | |
| Mar2024 | 12.71% | -27.50 | |
| Mar2023 | 17.53% | -6.61 | |
| Mar2022 | 18.77% | 3.59 | |
| Mar2021 | 18.12% | - | |
HIKAL Profit After Tax
[BOM: 524735|NSE : HIKAL]
| Y-o-Y | -11.20 % |
| 5 Yr CAGR | -4.72 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹70 Cr | -11.20 | |
| Mar2024 | ₹78 Cr | -51.16 | |
| Mar2023 | ₹160 Cr | 20.55 | |
| Mar2022 | ₹133 Cr | 57.68 | |
| Mar2021 | ₹84 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 25.13 % |
| 5 Yr CAGR | -10.89 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 4.88 % | 25.13 | |
| Mar2024 | 3.9 % | 0.78 | |
| Mar2023 | 3.87 % | -53.15 | |
| Mar2022 | 8.26 % | 6.72 | |
| Mar2021 | 7.74 % | - | |
HIKAL Earnings Per Share (EPS)
[BOM: 524735|NSE : HIKAL]
| Y-o-Y | 30.32 % |
| 5 Yr CAGR | -9.17 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹7.35 | 30.32 | |
| Mar2024 | ₹5.64 | -11.32 | |
| Mar2023 | ₹6.36 | -51.15 | |
| Mar2022 | ₹13 | 20.56 | |
| Mar2021 | ₹11 | - | |
HIKAL Return on Capital Employed (ROCE)
[BOM: 524735|NSE : HIKAL]
| Y-o-Y | 26.34 % |
| 5 Yr CAGR | -11.56 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 9.88% | 26.34 | |
| Mar2024 | 7.82% | -7.67 | |
| Mar2023 | 8.47% | -44.31 | |
| Mar2022 | 15.21% | -5.82 | |
| Mar2021 | 16.15% | - | |
HIKAL Share Price vs Sensex
| Current Share Price | : | ₹232.7 |
| Current MarketCap | : | ₹ 2,868.6 Cr |
| Updated EOD on | : | Nov 07,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -2.5% |
-7.1% |
-38.8% |
| SENSEX | -1.4% |
1.7% |
4.8% |
HIKAL related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 6.4% | 8.9% | 7.5% |
| BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
| BSE HEALTHCARE | -1.2% | 0.8% | 1% |
| BSE SMALLCAP | -1.9% | -0.4% | -3.5% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY TOTAL MARKET | -1.3% | 1.5% | 3.3% |
| NIFTY MICROCAP 250 | -1.3% | 0.5% | -5.3% |
You may also like the below Video Courses
FAQ about HIKAL Financials
How the annual revenues of HIKAL have changed ?
The Revenues of HIKAL have decreased by -11.79% YoY .
How the Earnings per Share (EPS) of HIKAL have changed?
The Earnings Per Share (EPS) of HIKAL has increased by 30.32 % YoY .
Check out Intrinsic Value of Peers of HIKAL
Compare Stock Analytics of Peers of HIKAL
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
